בשל "הגנת זכויות יוצרים", מובא להלן קישור למאמר בלבד. לקריאתו בטקסט מלא, אנא פנה לספרייה הרפואית הזמינה לך.

With the announcement by the Royal College of Anaesthetists of the National Audit Programme 7 (NAP7) on perioperative cardiac arrest, it is opportune to examine the management of early perioperative ST-elevation myocardial infarction (STEMI), a life-threatening, adverse event.

With pharmacological and technical developments in coronary reperfusion over recent decades, together with substantial evidence on the impact of early reperfusion on survival, primary percutaneous coronary intervention (pPCI) has evolved as first-line treatment for STEMI.